Device Trial Radar · NCT02187770
Precision of IMED-4 Lung Fluid Measurements
Last checked: Nov 20, 2026Latest source record: Oct 14, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
46
Actual
Start
Jul 2014
Primary completion
Sep 2015
Study completion Oct 2015
Sponsor
- Lead sponsor
- Intersection Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 11, 2014
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if IMED-4 recordings have sufficient precision to detect a clinically significant change in lung fluid status in acute heart failure syndrome with pulmonary congestion.
Conditions
- Dyspnea
- Acute Heart Failure Syndrome
- Pulmonary Congestion
Interventions
IMED-4Device
Non invasive recording electrode used to assess lung fluid
Primary outcomes
What the sponsor says the trial is designed to measure.
- Lung Fluid StatusTime frame: Up to 1 year
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Mass General Hospital
Boston, Massachusetts
Henry Ford Hospital
Detroit, Michigan
Ohio State University
Columbus, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.